Innovotech Signs Collaboration Agreement for InnovoSIL(TM)-1

About this update from Innovotech Inc.

[{"type":"text","content":"Innovotech Signs Collaboration Agreement for InnovoSIL(TM)-1(via TheNewswire)\n \n \nEdmonton - TheNewswire - July 14, 2020. Innovotech (TSXV:IOT), reports the signing of a 5-year Material Transfer and Collaboration Agreement with a global medical device company for its InnovoSIL(TM)-1 silver periodate (Ag5IO6) antimicrobial compound.\n\n\n \n \"We have worked with our partner for over two years to develop this application for InnovoSIL(TM)-1 and it is good to see that the project has advanced to a new stage,\" said Dr. Amin Omar, Chief Operating Officer.\n\n\n \nUnder the Agreement, Innovotech will receive annual payments plus costs for new, divisional, and continuing patent applications related to the collaboration with our partner. Innovotech will supply materials and its expertise to assist in the commercial development of medical devices within the scope of the Agreement.\n\n\n \nThe Agreement grants our collaborator an exclusive right to obtain a license or acquire the rights to existing Innovotech technology in new applications and patents that may be filed for the purposes contemplated. \n\n\n \nThe Agreement calls for a negotiated Commercialization Agreement at any time during its term. Meanwhile, Innovotech is free to pursue applications of InnovoSIL(TM)-1 outside of those areas that are precluded by the Agreement's focus. As is customary in such agreements, our collaborator has the right to terminate the Agreement at any time during its term.\n\n\n \nAbout InnovoSIL(TM)-1\n\n\n \nInnovoSIL(TM)-1 possesses exceptional properties for efficacy against microbial biofilms as well as simplicity for coating onto or incorporating into medical devices, with favorable release characteristics. The unique structure around the anionic silver slows its inactivation by bodily fluids. Combining silver and iodine increases antimicrobial mechanisms of action, reducing the likelihood of a target developing resistance to it. InnovoSIL(TM)-1 has demonstrated excellent stability under a wide variety of challenges and can be easily synthesised with high purity in a form that is simple to deposit onto metals or incorporate into wound dressings, gels or polymers. \n\n\n \nThe first stage in the process of the development of chronic infections associated with medical devices is the adherence and colonization of microorganisms which, if not eli...

More updates from Innovotech Inc.